There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...